SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-20-004645
Filing Date
2020-02-24
Accepted
2020-02-24 16:41:33
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32020_aytubioscience.htm S-3 660574
2 OPINION OF DORSEY & WHITNEY LLP fs32020ex5-1_aytubio.htm EX-5.1 8994
3 CONSENTOF PLANTE & MORAN, PLLC RELATING TO AYTU'S FINANCIAL STATEMENTS fs32020ex23-2_aytubio.htm EX-23.2 2209
4 CONSENTOF HALL & COMPANY RELATING TO INNOVUS' FINANCIAL STATEMENTS fs32020ex23-3_aytubio.htm EX-23.3 2458
5 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF THE ABBREVIATED FINANCIAL fs32020ex23-4_aytubio.htm EX-23.4 2678
6 CONSENTOF EKS&H LLLP, PREDECESSOR INDEPENDENT PUBLIC ACCOUNTING FIRM, RELATING T fs32020ex23-5_aytubio.htm EX-23.5 2299
7 GRAPHIC img_001.jpg GRAPHIC 7949
8 GRAPHIC ex23-3_001.jpg GRAPHIC 29674
  Complete submission text file 0001213900-20-004645.txt   732486
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-236599 | Film No.: 20644933
SIC: 2834 Pharmaceutical Preparations